Head-Only Draping in Pediatric Tonsillectomy
30-Day Postoperative Infection Rate in Pediatric Tonsillectomy: Head-Drape vs. Full-Body Surgical Draping
1 other identifier
interventional
200
1 country
1
Brief Summary
This single-center, interventional study will compare 30-day postoperative infection rates in pediatric tonsillectomy performed with either head-only draping or traditional full-body draping. Secondary analyses will evaluate differences in waste production, material and disposal costs, and provider attitudes between the two draping techniques. This study will randomize participants 1:1 to either the head-only draping cohort (intervention) or the full-body draping cohort (control).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 9, 2026
CompletedFirst Posted
Study publicly available on registry
January 16, 2026
CompletedStudy Start
First participant enrolled
February 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
January 16, 2026
January 1, 2026
7 months
January 9, 2026
January 9, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
30-day postoperative infection rate
Day 30 Post Operation
Secondary Outcomes (2)
Total weight of waste
Day 0 (Day of Operation)
Disposal costs
Day 0 (Day of Operation)
Study Arms (2)
Head-Only Draping
EXPERIMENTALPediatric tonsillectomy will be performed with head-only draping.
Full-Body Draping
ACTIVE COMPARATORPediatric tonsillectomy will be performed with traditional full-body draping.
Interventions
Eligibility Criteria
You may qualify if:
- Pediatric patients \<18 years at time of surgery.
- Scheduled for tonsillectomy, with or without adenoidectomy, without any other procedures requiring full-body draping.
- Ability to complete 30-day outcome assessment (i.e., remain in follow-up or reachable via phone/electronic health record).
- Parent/guardian able to provide parental permission and consent for both them and their children.
You may not qualify if:
- Significant deviation from planned surgical technique during case.
- Pre-existing systemic infection prior to surgery.
- Known immunodeficiency or current systemic immunosuppressive therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
NYU Langone Health
New York, New York, 10016, United States
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Neelima Tummala, MD
NYU Langone Health
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 9, 2026
First Posted
January 16, 2026
Study Start
February 2, 2026
Primary Completion (Estimated)
August 31, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
- Access Criteria
- The investigator who proposed to use the data will be granted access upon reasonable request. Requests should be directed to neelima.tummala@nyulangone.org. To gain access, data requestors will need to sign a data access agreement. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's DSSB.
The de-identified participant data from the final research dataset will be shared upon reasonable request beginning 9 to 36 months after publication or as required by a condition of awards or supporting agreements, provided the requesting investigator executes a data use agreement with NYU Langone Health. This instance of data sharing will also require separate IRB review as well as review from NYU Langone's Data Sharing Strategy Board (DSSB). Requests should be directed to: neelima.tummala@nyulangone.org. The protocol and statistical analysis plan will be posted on Clinicaltrials.gov only as required by federal regulation or supporting awards and agreements.